Biomaterials in Tissue Engineering and Regenerative Medicine 2021
DOI: 10.1007/978-981-16-0002-9_16
|View full text |Cite
|
Sign up to set email alerts
|

Intelligent Biomaterials for Tissue Engineering and Biomedical Applications: Current Landscape and Future Prospects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 97 publications
0
4
0
Order By: Relevance
“…), polymers and nanoparticles as drug delivery systems (DSS) [14]. In the last few years, the emerging fourth generation of biomaterials have been identified [15][16][17][18][19]. Among them, new materials consisting of biomimetic, or smart, materials [15], often incorporating electroactive biosensors capable of monitoring and manipulating bioelectric cell signals [16], new biodegradable alloys (e.g.…”
Section: Third Generation Biomaterialsmentioning
confidence: 99%
“…), polymers and nanoparticles as drug delivery systems (DSS) [14]. In the last few years, the emerging fourth generation of biomaterials have been identified [15][16][17][18][19]. Among them, new materials consisting of biomimetic, or smart, materials [15], often incorporating electroactive biosensors capable of monitoring and manipulating bioelectric cell signals [16], new biodegradable alloys (e.g.…”
Section: Third Generation Biomaterialsmentioning
confidence: 99%
“…To this end, stimuli-responsive biomaterials represent an exciting prospect in scaffold design. [2,[5][6][7][8][9] This subset of biomaterials is distinguished by their capacity to alter their physiochemical properties in response to exogenous variables or events, ultimately accommodating a more dynamically nuanced recapitulation of native tissues as compared to their static counterparts. [5,9] While physiologically inherent factors have been explored as potential endogenous stimuli (e.g., pH, enzymes, small biological molecules, redox potentials), biomaterials that respond to externally generated, easily attenuated stimuli currently hold the greatest translational promise.…”
Section: Introductionmentioning
confidence: 99%
“…These MNPs are either blended ("doped") into the respective polymers prior to scaffold fabrication, introduced as a coating post-fabrication via covalently bonding to the biomaterial surface, or precipitated out of aqueous metal ion solutions and deposited onto the scaffold during fabrication ("in situ precipitation"). [2,8,[15][16][17][18] For biomedical applications, MNPs are traditionally synthesized from ironbased oxides, particularly magnetite (Fe 3 O 4 ) or its oxidized form, maghemite (𝛾-Fe 2 O 3 ). [19][20][21] Relative to other metal oxides, ironbased oxides exhibit particularly high magnetic saturation levels (i.e., high magnetic moment per unit volume) that impart significant magneto-responsiveness to functionalized scaffolds with limited increase in metal content.…”
Section: Introductionmentioning
confidence: 99%
“…With decades of advancements in materials science, novel approaches are adopted to develop biomaterials. Intelligent biomaterials are used instead of inert materials that were previously used for applications such as tissue engineering [4]. The recent emergence of microfabrication technologies has enabled the development of intelligent biomaterials for biological applications; such biomaterials can self-regulate their properties and functions in response to exogenous stimuli [5].…”
Section: Introductionmentioning
confidence: 99%